Young Iee Park

635 total citations
22 papers, 430 citations indexed

About

Young Iee Park is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Young Iee Park has authored 22 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 8 papers in Surgery. Recurrent topics in Young Iee Park's work include Gastric Cancer Management and Outcomes (18 papers), Colorectal Cancer Treatments and Studies (9 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Young Iee Park is often cited by papers focused on Gastric Cancer Management and Outcomes (18 papers), Colorectal Cancer Treatments and Studies (9 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Young Iee Park collaborates with scholars based in South Korea, Japan and United States. Young Iee Park's co-authors include Sook Ryun Park, Il Ju Choi, Chan Gyoo Kim, Young‐Woo Kim, Jong Yeul Lee, Soo‐Jeong Cho, Keun Won Ryu, Jun Ho Lee, Byung‐Ho Nam and Mi Jung Kim and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Gastrointestinal Endoscopy.

In The Last Decade

Young Iee Park

22 papers receiving 421 citations

Peers

Countries citing papers authored by Young Iee Park

Since Specialization

Citations

This map shows the geographic impact of Young Iee Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young Iee Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young Iee Park more than expected).

Fields of papers citing papers by Young Iee Park

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Young Iee Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young Iee Park. The network helps show where Young Iee Park may publish in the future.

Co-authorship network of co-authors of Young Iee Park

This figure shows the co-authorship network connecting the top 25 collaborators of Young Iee Park. A scholar is included among the top collaborators of Young Iee Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Young Iee Park. Young Iee Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Comprehensive and Comparative Review of Global Gastric Cancer Treatment Guidelines 2022 ·Journal of the Korean Gastric Cancer Association ·(unknown), Wonyoung Choi, Bang Wool Eom, (unknown), (unknown), Young‐Il Kim, Hong Man Yoon, Jong Yeul Lee, Chan Gyoo Kim, Hark Kyun Kim, Myeong‐Cherl Kook, Il Ju Choi, Young‐Woo Kim, Young Iee Park, Keun Won Ryu	36
2	Determinants of clinical outcomes of gastric cancer patients treated with neoadjuvant chemotherapy: a sub-analysis of the PRODIGY study 2022 ·Gastric Cancer ·Hyung‐Don Kim, Jong Seok Lee, Young Soo Park, Jeong Hwan Yook, Sung Hoon Noh, Youngkyu Park, Young‐Woo Kim, Sang Cheul Oh, Jong Gwang Kim, Min‐Hee Ryu, Jae‐Ho Cheong, Hyunki Kim, Joon Seok Lim, Jae-Hyuk Lee, Suk Hee Heo, Jin Young Kim, Mi Hwa Heo, Young Iee Park, Inho Kim, Yoon‐Koo Kang	4
3	Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE) 2022 ·Cancer Medicine ·Min‐Hee Ryu, Kyung Hee Lee, Lin Shen, Kun‐Huei Yeh, Changhoon Yoo, Young Seon Hong, Young Iee Park, Sung Hyun Yang, Dong Bok Shin, Dae Young Zang, Won Ki Kang, Ik‐Joo Chung, Yeul Hong Kim, Baek‐Yeol Ryoo, Byung‐Ho Nam, Young Soo Park, Yoon‐Koo Kang	9
4	Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial) 2020 ·Gastric Cancer ·Keun-Wook Lee, Ik‐Joo Chung, Min‐Hee Ryu, Young Iee Park, Byung‐Ho Nam, (unknown), Kyung Hee Lee, Hye Sook Han, (unknown), Jae‐Cheol Jo, (unknown), Jin Won Kim, Sook Ryun Park, Sang‐Hee Cho, Yoon‐Koo Kang, (unknown)	33
5	A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer 2019 ·Gastric Cancer ·Tae Yong Kim, Hye Sook Han, Keun‐Wook Lee, Dae Young Zang, Sun Young Rha, Young Iee Park, Jin Soo Kim, Kyung-Hun Lee, Se Hoon Park, Eun‐Kee Song, (unknown), (unknown), Yeul Hong Kim, Y. Choi, Yung‐Jue Bang	32
6	Nomograms predicting survival of patients with unresectable or metastatic gastric cancer who receive combination cytotoxic chemotherapy as first-line treatment 2017 ·Gastric Cancer ·Sun Young Kim, (unknown), Young Iee Park, Mi Jung Kim, Byung‐Ho Nam, Sook Ryun Park	46
7	Effect of a Proton Pump Inhibitor on Tumor Bleeding Prevention in Unresectable Gastric Cancer Patients: a Double-Blind, Randomized, Placebo-Controlled Trial 2017 ·Journal of the Korean Gastric Cancer Association ·Young‐Il Kim, Mi‐Jung Kim, Sook Ryun Park, Hark Kyun Kim, Soo‐Jeong Cho, Jong Yeul Lee, Chan Gyoo Kim, Gwang Ha Kim, Moo In Park, Byung‐Ho Nam, Young Iee Park, Il Ju Choi	8
8	A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus Cisplatin vs. Docetaxel Plus S-1 as Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed after Cisplatin Plus Either S-1 or Capecitabine 2016 ·Cancer Research and Treatment ·Keun-Wook Lee, Bum Jun Kim, Mi Jung Kim, Hye Sook Han, Jin Won Kim, Young Iee Park, Sook Ryun Park	14
9	Phase III trial of s-1 plus oxaliplatin (SOX) vs s-1 plus cisplatin (SP) combination chemotherapy for first-line treatment of advanced gastric cancer (AGC): SOPP study. 2016 ·Journal of Clinical Oncology ·Min‐Hee Ryu, Young Iee Park, Ik‐Joo Chung, Keun‐Wook Lee, (unknown), Kyung Hee Lee, Hye Sook Han, (unknown), Jae‐Cheol Jo, (unknown), Sook Ryun Park, Yoon‐Koo Kang	7
10	Avelumab (MSB0010718C; anti-PD-L1) + best supportive care (BSC) vs BSC ± chemotherapy as third-line treatment for patients with unresectable, recurrent, or metastatic gastric cancer: The phase 3 JAVELIN Gastric 300 trial. 2016 ·Journal of Clinical Oncology ·Yung‐Jue Bang, Lucjan Wyrwicz, Young Iee Park, Min‐Hee Ryu, (unknown), Carlos Gómez-Martín, Rosine Guimbaud, Fortunato Ciardiello, Narikazu Boku, Eric Van Cutsem, Julien Taı̈eb, Huiling Xiong, (unknown), Jean-Marie Cuillerot, Jayne S. Gurtler	7
11	Efficacy and safety findings from DREAM: A phase III study of DHP107 (oral paclitaxel) vs IV paclitaxel in patients with gastric cancer after failure of first-line chemotherapy. 2016 ·Journal of Clinical Oncology ·Yoon‐Koo Kang, Min‐Hee Ryu, Se Hoon Park, Sook Ryun Park, Jong Gwang Kim, Jin Won Kim, Sang‐Hee Cho, Young Iee Park, Sun Young Rha, Myoung Joo Kang, Y. Choi, Seok Yun Kang, Young Seon Hong, Baek‐Yeol Ryoo, Byung‐Ho Nam, Yeong Woo Jo, (unknown), Sang Cheul Oh	8
12	Phase I/II Study of Weekly Oraxol for the Second-Line Treatment of Patients With Metastatic or Recurrent Gastric Cancer 2015 ·The Oncologist ·Keun‐Wook Lee, Kyung Hee Lee, Dae Young Zang, Young Iee Park, Dong Bok Shin, Jin Won Kim, Seock‐Ah Im, (unknown), Kyung‐Sang Yu, Joo‐Youn Cho, Jina Jung, Yung‐Jue Bang	17
13	A phase III study to compare efficacy and safety of DHP107 (oral paclitaxel) versus IV paclitaxel in patients with metastatic or recurrent gastric cancer after failure of first-line chemotherapy (DREAM). 2015 ·Journal of Clinical Oncology ·Sang Cheul Oh, Min‐Hee Ryu, Se Hoon Park, Baek‐Yeol Ryoo, Sook Ryun Park, Jong Gwang Kim, Jin Won Kim, Ik‐Joo Chung, Young Iee Park, Sun Young Rha, Myoung Joo Kang, Y. Choi, Seok Yun Kang, Young Seon Hong, Byung‐Ho Nam, (unknown), (unknown), Yoon‐Koo Kang	1
14	Lipid MALDI MS Profiles of Gastric Cancer 2014 ·KUMeL Repository (Keimyung University) ·Sun Young Kwon, Seung Ho Choi, Young Soo Park, Do Youn Park, Young Iee Park, Ilseon Hwang, Min Hee Ryu, Chae Hwa Kwon, Jeong Hwa Lee, Geul Bang, Kwang Pyo Kim, Young Hwan Kim, Hark Kyun Kim	7
15	Sa1677 Risk Scoring Systems in Predicting Intervention and Clinical Outcomes of Bleeding in Patients With Unresectable Gastric Cancer 2014 ·Gastrointestinal Endoscopy ·(unknown), Il Ju Choi, Soo‐Jeong Cho, Jong Yeul Lee, Chan Gyoo Kim, Mi‐Jung Kim, Hark Kyun Kim, Young Iee Park	1
16	Phase III trial of a 3-weekly versus 5-weekly schedule of S-1 plus cisplatin (SP) combination chemotherapy for first-line treatment of advanced gastric cancer (AGC): SOS study. 2013 ·Journal of Clinical Oncology ·Min‐Hee Ryu, Eishi Baba, Kyung Hee Lee, Narikazu Boku, Young Iee Park, Ichinosuke Hyodo, Byung‐Ho Nam, Taito Esaki, Baek‐Yeol Ryoo, Eun‐Kee Song, Sang‐Hee Cho, Sung Sook Lee, Won Ki Kang, Sung Hyun Yang, Dae Young Zang, Dong Bok Shin, Sook Ryun Park, Katsunori Shinozaki, Toshimi Takano, Yoon‐Koo Kang, (unknown)	5
17	Outcome of endoscopic therapy for cancer bleeding in patients with unresectable gastric cancer 2013 ·Journal of Gastroenterology and Hepatology ·Young‐Il Kim, Il Ju Choi, Soo‐Jeong Cho, Jong Yeul Lee, Chan Gyoo Kim, Mi‐Jung Kim, Keun Won Ryu, Young‐Woo Kim, Young Iee Park	48
18	Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study 2010 ·Gastrointestinal Endoscopy ·Chan Gyoo Kim, Il Ju Choi, Jong Yeul Lee, Soo‐Jeong Cho, Sook Ryun Park, Jun Ho Lee, Keun Won Ryu, Young‐Woo Kim, Young Iee Park	105
19	Tumor Lysis Syndrome After Capecitabine Plus Cisplatin Treatment in Advanced Gastric Cancer 2008 ·Journal of Clinical Oncology ·Hye‐Suk Han, Sook Ryun Park, Sun Young Kim, Young Iee Park, Jong Seok Lee, Myeong‐Cherl Kook, Il Ju Choi, Chan Gyoo Kim, (unknown), Soo‐Jeong Cho, (unknown)	17
20	A Phase I study ofcis-malonato[(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane] platinum(II) in patients with advanced malignancies 2001 ·Cancer ·(unknown), Tae-You Kim, (unknown), Young Iee Park, Jung Ae Lee, (unknown), (unknown), Dae-Kee Kim, Dae Seog Heo, (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact